Pokhylevych, Halyna MD∗; Khose, Swapnil MD∗; Gule-Monroe, Maria K. MD∗; Chen, Melissa M. MD∗; Fuller, Greg MD, PhD†; Gruschkus, Stephen K. PhD‡; Sadighi, Zsila MD§; Zaky, Wafik MD§; Sandberg, David I. MD∥; McGovern, Susan L. MD¶; Johnson, Jason M. MD∗
From the Departments of ∗Neuroradiology
†Pathology
‡Biostatistics
§Pediatric Neuro-Oncology
∥Neurosurgery
¶Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Received for publication September 16, 2021; accepted February 7, 2022.
Correspondence to: Halyna Pokhylevych, MD, Department of Neuroradiology, MD Anderson Cancer Center, 1200 Brookwood Dr, Apt 211, Little Rock, AR 72202 (e-mail: [email protected]).
The authors declare no conflict of interest.
The authors did not receive funding for research on which this article is based from any of the following organizations: National Institutes of Health, Wellcome Trust, and Howard Hughes Medical Institute.
